Lung Cancer Clinical Trial

Using Urine Samples to Identify Lung Cancer

Summary

The researchers are doing this study to test the ability of an animal biosensor platform (ABP) to detect NSCLC. Participants in this study will either be diagnosed with NSCLC, suspected to have NSCLC, or have not been diagnosed or suspected to have NSCLC.

The ABP test uses laboratory animals that are trained to detect (by smell) different chemicals in urine. Studies show that people with lung cancer have unique chemicals in their urine that are not present in people without lung cancer, and researchers think these chemicals can be used to identify people with lung cancer without the need for invasive procedures (like biopsy).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Phase I (with NSCLC): Aged 18 to 90 years with histologically proven, previously untreated stage I, II, or IIIA NSCLC
Phase I (without NSCLC): Aged 18 to 90 years with patient confirmed absence of NSCLC
Phase II: Aged 18 to 90 years with suspected but undiagnosed stage I, II, or IIIA NSCLC by CT and/or PET scan criteria

Exclusion Criteria:

Aged <18 years
Lack of available results from low-dose CT
Receipt of radiation, chemotherapy, biological therapy, resection, or any other treatment for any cancer in the previous year
Pregnant (for women)
Taking drugs that affect the immune system
Chronic disease related to the immune system
Missing clinical data (i.e., current clinical staging)

Study is for people with:

Lung Cancer

Estimated Enrollment:

210

Study ID:

NCT06033248

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown New Jersey, 07748, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale New Jersey, 07645, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities)
Commack New York, 11725, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison New York, 10604, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale New York, 11553, United States More Info
Gaetano Rocco, MD
Contact
212-639-3478

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

210

Study ID:

NCT06033248

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.